Log in

NASDAQ:KIDS - Orthopediatrics Stock Price, Forecast & News

$48.61
-0.39 (-0.80 %)
(As of 02/24/2020 09:08 AM ET)
Today's Range
$48.16
Now: $48.61
$49.06
50-Day Range
$45.93
MA: $47.74
$49.04
52-Week Range
$28.19
Now: $48.61
$51.48
Volume101,973 shs
Average Volume100,748 shs
Market Capitalization$812.76 million
P/E RatioN/A
Dividend YieldN/A
Beta0.3
OrthoPediatrics Corp., a medical device company, designs, develops, and markets anatomically appropriate implants and devices for the treatment of children with orthopedic conditions in the United States and internationally. The company's products comprise PediLoc, PediPlates, cannulated screws, PediFlex nail, PediNail products, PediLoc tibia products, anterior cruciate ligament reconstruction systems, locking cannulated blades, locking proximal femurs, RESPONSE Spine systems, Bandloc, and Pediguard. Read More…

Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:KIDS
CUSIPN/A
Phone574-268-6379

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$57.56 million
Book Value$6.38 per share

Profitability

Net Income$-12,020,000.00

Miscellaneous

Employees80
Market Cap$812.76 million
Next Earnings Date3/4/2020 (Confirmed)
OptionableNot Optionable

Receive KIDS News and Ratings via Email

Sign-up to receive the latest news and ratings for KIDS and its competitors with MarketBeat's FREE daily newsletter.


Orthopediatrics (NASDAQ:KIDS) Frequently Asked Questions

What is Orthopediatrics' stock symbol?

Orthopediatrics trades on the NASDAQ under the ticker symbol "KIDS."

How were Orthopediatrics' earnings last quarter?

Orthopediatrics Corp (NASDAQ:KIDS) issued its earnings results on Thursday, November, 7th. The company reported ($0.18) EPS for the quarter, missing the Zacks' consensus estimate of ($0.17) by $0.01. The firm earned $20.74 million during the quarter, compared to analysts' expectations of $19.87 million. Orthopediatrics had a negative net margin of 15.80% and a negative return on equity of 12.12%. Orthopediatrics's quarterly revenue was up 31.1% on a year-over-year basis. During the same quarter in the prior year, the company earned ($0.15) EPS. View Orthopediatrics' Earnings History.

When is Orthopediatrics' next earnings date?

Orthopediatrics is scheduled to release their next quarterly earnings announcement on Wednesday, March 4th 2020. View Earnings Estimates for Orthopediatrics.

How can I listen to Orthopediatrics' earnings call?

Orthopediatrics will be holding an earnings conference call on Wednesday, March 4th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

What guidance has Orthopediatrics issued on next quarter's earnings?

Orthopediatrics issued an update on its fourth quarter 2019 Pre-Market earnings guidance on Monday, January, 13th. The company provided EPS guidance of for the period. The company issued revenue guidance of $19-19 million, compared to the consensus revenue estimate of $18.24 million.

What price target have analysts set for KIDS?

4 brokerages have issued 12 month price targets for Orthopediatrics' stock. Their forecasts range from $44.00 to $54.00. On average, they anticipate Orthopediatrics' share price to reach $50.25 in the next twelve months. This suggests a possible upside of 3.4% from the stock's current price. View Analyst Price Targets for Orthopediatrics.

What is the consensus analysts' recommendation for Orthopediatrics?

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Orthopediatrics in the last year. There are currently 4 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Orthopediatrics.

Has Orthopediatrics been receiving favorable news coverage?

Media coverage about KIDS stock has trended negative this week, InfoTrie Sentiment Analysis reports. The research group identifies positive and negative press coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. Orthopediatrics earned a daily sentiment score of -2.1 on InfoTrie's scale. They also gave news articles about the company a news buzz of 2.0 out of 10, indicating that recent press coverage is very unlikely to have an effect on the stock's share price in the next few days. View News Stories for Orthopediatrics.

Who are some of Orthopediatrics' key competitors?

What other stocks do shareholders of Orthopediatrics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Orthopediatrics investors own include AbbVie (ABBV), Freeport-McMoRan (FCX), Akorn (AKRX), Gilead Sciences (GILD), Enterprise Products Partners (EPD), Advanced Micro Devices (AMD), Intel (INTC), Nektar Therapeutics (NKTR), Boeing (BA) and Honeywell International (HON).

Who are Orthopediatrics' key executives?

Orthopediatrics' management team includes the folowing people:
  • Mr. Mark C. Throdahl, Pres, CEO & Director (Age 68)
  • Mr. Fred L. Hite, CFO & Director (Age 51)
  • Mr. Daniel J. Gerritzen, VP of Legal & HR, Gen. Counsel and Sec. (Age 49)
  • Mr. David R. Bailey, Exec. VP (Age 40)
  • Mr. Gregory A. Odle, Exec. VP of Commercialization (Age 49)

When did Orthopediatrics IPO?

(KIDS) raised $52 million in an IPO on Thursday, October 12th 2017. The company issued 4,000,000 shares at a price of $12.00-$14.00 per share. Piper and Jaffray Stifel acted as the underwriters for the IPO and William Blair and BTIG were co-managers.

Who are Orthopediatrics' major shareholders?

Orthopediatrics' stock is owned by many different of institutional and retail investors. Top institutional shareholders include Riverbridge Partners LLC (4.48%), Massachusetts Financial Services Co. MA (4.21%), Driehaus Capital Management LLC (2.93%), FMR LLC (2.52%), Lord Abbett & CO. LLC (1.61%) and State Street Corp (1.01%). Company insiders that own Orthopediatrics stock include Daniel J Gerritzen, David R Bailey, David R Pelizzon, Fred Hite, Kevin Unger and Mark C Throdahl. View Institutional Ownership Trends for Orthopediatrics.

Which major investors are selling Orthopediatrics stock?

KIDS stock was sold by a variety of institutional investors in the last quarter, including Prospect Capital Advisors LLC, Schonfeld Strategic Advisors LLC, New York State Common Retirement Fund, Blair William & Co. IL, Victory Capital Management Inc., Stifel Financial Corp, Brasada Capital Management LP and Victory Capital Management Inc.. Company insiders that have sold Orthopediatrics company stock in the last year include David R Bailey and Mark C Throdahl. View Insider Buying and Selling for Orthopediatrics.

Which major investors are buying Orthopediatrics stock?

KIDS stock was acquired by a variety of institutional investors in the last quarter, including Riverbridge Partners LLC, CWM LLC, FMR LLC, Parkman Healthcare Partners LLC, Bank of America Corp DE, Massachusetts Financial Services Co. MA, Monashee Investment Management LLC and Royce & Associates LP. View Insider Buying and Selling for Orthopediatrics.

How do I buy shares of Orthopediatrics?

Shares of KIDS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Orthopediatrics' stock price today?

One share of KIDS stock can currently be purchased for approximately $48.61.

How big of a company is Orthopediatrics?

Orthopediatrics has a market capitalization of $812.76 million and generates $57.56 million in revenue each year. The company earns $-12,020,000.00 in net income (profit) each year or ($0.96) on an earnings per share basis. Orthopediatrics employs 80 workers across the globe.View Additional Information About Orthopediatrics.

What is Orthopediatrics' official website?

The official website for Orthopediatrics is http://www.orthopediatrics.com/.

How can I contact Orthopediatrics?

Orthopediatrics' mailing address is 2850 Frontier Drive, Warsaw IN, 46582. The company can be reached via phone at 574-268-6379 or via email at [email protected]


MarketBeat Community Rating for Orthopediatrics (NASDAQ KIDS)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  253 (Vote Outperform)
Underperform Votes:  256 (Vote Underperform)
Total Votes:  509
MarketBeat's community ratings are surveys of what our community members think about Orthopediatrics and other stocks. Vote "Outperform" if you believe KIDS will outperform the S&P 500 over the long term. Vote "Underperform" if you believe KIDS will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/24/2020 by MarketBeat.com Staff

Featured Article: Range Trading

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel